Published on 18 Dec 2023 on Simply Wall St. via Yahoo Finance
CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Price Is Right But Growth Is Lacking After Shares Rocket...
Despite an already strong run, CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shares have been powering on, with a gain of 33% in the last thirty days. The annual gain comes to 256% following the latest surge, making investors sit up and take notice.
In spite of the firm bounce in price, CASI Pharmaceuticals' price-to-sales (or "P/S") ratio of 1.9x might still make it look like a strong buy right now compared to the wider Biotechs industry in the United States, where around half of the companies have P/S ratios above 11.6x and even P/S above 49x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
See our latest analysis for CASI Pharmaceuticals